Holdings of iShares Biotechnology ETF
iShares Trust ·246 declared positions · as of Mar 31, 2026
Original filing · Net assets 8.1B $ · Ten largest lines: 47.4 % of the equity sleeve
Sector breakdown
- Health care 50.8 %
- Materials 1.7 %
- Industrials 1.1 %
- Unattributed 46.4 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
- USD 100.0 %
The quoted currency of each line, as declared.
Country breakdown
- US 88.9 %
- NL 3.4 %
- DK 2.1 %
- BM 1.2 %
- CA 0.8 %
- DE 0.7 %
- IE 0.6 %
- FR 0.5 %
- CH 0.4 %
- KY 0.4 %
- SG 0.1 %
- JE 0.1 %
- Other countries 0.6 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | US | 208 | 7.2B $ | 88.91 % |
| 2 | NL | 4 | 279.1M $ | 3.44 % |
| 3 | DK | 2 | 173.1M $ | 2.13 % |
| 4 | BM | 1 | 100.9M $ | 1.24 % |
| 5 | CA | 4 | 67.1M $ | 0.83 % |
| 6 | DE | 1 | 53.3M $ | 0.66 % |
| 7 | IE | 3 | 50.9M $ | 0.63 % |
| 8 | FR | 2 | 42M $ | 0.52 % |
| 9 | CH | 3 | 35.3M $ | 0.44 % |
| 10 | KY | 5 | 34.8M $ | 0.43 % |
| 11 | SG | 1 | 8.5M $ | 0.11 % |
| 12 | JE | 1 | 8.3M $ | 0.10 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 201 | Keros Therapeutics Inc | 214,789 | 2.4M $ | 0.03 % |
| 202 | Fulgent Genetics Inc | 148,748 | 2.4M $ | 0.03 % |
| 203 | Tectonic Therapeutic Inc | 75,889 | 2.3M $ | 0.03 % |
| 204 | Aura Biosciences Inc | 338,128 | 2.3M $ | 0.03 % |
| 205 | Kyverna Therapeutics Inc | 251,263 | 2.2M $ | 0.03 % |
| 206 | Maravai LifeSciences Holdings Inc | 759,052 | 2.1M $ | 0.03 % |
| 207 | Immuneering Corp | 390,008 | 2.1M $ | 0.03 % |
| 208 | Anavex Life Sciences Corp | 668,447 | 2.1M $ | 0.03 % |
| 209 | Entrada Therapeutics Inc | 158,267 | 2M $ | 0.02 % |
| 210 | Ginkgo Bioworks Holdings Inc | 317,323 | 1.9M $ | 0.02 % |
| 211 | Upstream Bio Inc | 213,032 | 1.9M $ | 0.02 % |
| 212 | Neurogene Inc | 94,694 | 1.9M $ | 0.02 % |
| 213 | LENZ Therapeutics Inc | 206,971 | 1.9M $ | 0.02 % |
| 214 | Autolus Therapeutics PLC | 1,321,681 | 1.8M $ | 0.02 % |
| 215 | Editas Medicine Inc | 731,163 | 1.8M $ | 0.02 % |
| 216 | Cabaletta Bio Inc | 633,353 | 1.7M $ | 0.02 % |
| 217 | C4 Therapeutics Inc | 608,839 | 1.6M $ | 0.02 % |
| 218 | Larimar Therapeutics Inc | 350,415 | 1.6M $ | 0.02 % |
| 219 | Candel Therapeutics Inc | 294,995 | 1.4M $ | 0.02 % |
| 220 | Arcturus Therapeutics Holdings Inc | 186,967 | 1.4M $ | 0.02 % |
| 221 | OmniAb Inc | 874,147 | 1.4M $ | 0.02 % |
| 222 | NovaBridge Biosciences | 539,518 | 1.3M $ | 0.02 % |
| 223 | Voyager Therapeutics Inc | 329,043 | 1.3M $ | 0.02 % |
| 224 | AC Immune SA | 443,438 | 1.2M $ | 0.02 % |
| 225 | Bicycle Therapeutics PLC | 244,101 | 1.1M $ | 0.01 % |
| 226 | Caribou Biosciences Inc | 594,484 | 1.1M $ | 0.01 % |
| 227 | Codexis Inc | 683,417 | 1.1M $ | 0.01 % |
| 228 | Lyell Immunopharma Inc | 54,413 | 1.1M $ | 0.01 % |
| 229 | Cellectis SA | 339,873 | 1.1M $ | 0.01 % |
| 230 | Foghorn Therapeutics Inc | 223,190 | 1.1M $ | 0.01 % |
| 231 | Quanterix Corp | 284,827 | 1M $ | 0.01 % |
| 232 | Sagimet Biosciences Inc | 189,187 | 988.5K $ | 0.01 % |
| 233 | Quantum-Si Inc | 1,223,534 | 947K $ | 0.01 % |
| 234 | Silence Therapeutics PLC | 173,313 | 913.4K $ | 0.01 % |
| 235 | Tenaya Therapeutics Inc | 1,200,002 | 830.9K $ | 0.01 % |
| 236 | Neumora Therapeutics Inc | 421,430 | 821.8K $ | 0.01 % |
| 237 | PepGen Inc | 451,333 | 798.9K $ | 0.01 % |
| 238 | Humacyte Inc | 1,222,120 | 741.5K $ | 0.01 % |
| 239 | Black Diamond Therapeutics Inc | 321,542 | 684.9K $ | 0.01 % |
| 240 | Pyxis Oncology Inc | 345,130 | 503.9K $ | 0.01 % |
| 241 | Gossamer Bio Inc | 1,510,536 | 496.2K $ | 0.01 % |
| 242 | Jyong Biotech Ltd. | 206,499 | 444K $ | 0.01 % |
| 243 | Aardvark Therapeutics Inc | 89,682 | 338.1K $ | 0.00 % |
| 244 | Immutep Ltd | 809,244 | 284K $ | 0.00 % |
| 245 | Alpha Teknova Inc | 79,636 | 230.1K $ | 0.00 % |
| 246 | Third Harmonic Bio Inc | 134,478 | 1.3 $ |